2011
DOI: 10.1345/aph.1q279
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous Recall Phenomenon with Vinorelbine

Abstract: PublishedOnline, 23 Aug 20II, theannals .com 001 1O.I345/aph.IQ279 Comment: Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder TOTHE EDITOR: In light of differences in safety,efficacy,and cost-effectiveness profiles of different selective serotonin reuptake inhibitors (5S-Rls), controversy surrounds therapeutic substitution of a branded drug theannals.com

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0
1

Year Published

2020
2020
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 7 publications
0
2
0
1
Order By: Relevance
“…Vinorelbine is a semisynthetic vinca alkaloid that interferes with microtubule assembly. Cutaneous side effects related to vinorelbine chemotherapy include erythema at the injection site, skin necrosis as a result of extravasation of the agent, erythrodysesthesia, morbilliform drug eruption, serpentine supravenous hyperpigmentation, radiation recall dermatitis, and leukocytoclastic vasculitis [9][10][11][12][13][14]. Up to 28 % of patients receiving vinorelbine are reported to have injection site reactions, but we could find no previous reports of PG arising at a vinorelbine infusion site [9].…”
Section: Dear Editorsmentioning
confidence: 99%
See 1 more Smart Citation
“…Vinorelbine is a semisynthetic vinca alkaloid that interferes with microtubule assembly. Cutaneous side effects related to vinorelbine chemotherapy include erythema at the injection site, skin necrosis as a result of extravasation of the agent, erythrodysesthesia, morbilliform drug eruption, serpentine supravenous hyperpigmentation, radiation recall dermatitis, and leukocytoclastic vasculitis [9][10][11][12][13][14]. Up to 28 % of patients receiving vinorelbine are reported to have injection site reactions, but we could find no previous reports of PG arising at a vinorelbine infusion site [9].…”
Section: Dear Editorsmentioning
confidence: 99%
“…Cutaneous side effects related to vinorelbine chemotherapy include erythema at the injection site, skin necrosis as a result of extravasation of the agent, erythrodysesthesia, morbilliform drug eruption, serpentine supravenous hyperpigmentation, radiation recall dermatitis, and leukocytoclastic vasculitis [9][10][11][12][13][14]. Cutaneous side effects related to vinorelbine chemotherapy include erythema at the injection site, skin necrosis as a result of extravasation of the agent, erythrodysesthesia, morbilliform drug eruption, serpentine supravenous hyperpigmentation, radiation recall dermatitis, and leukocytoclastic vasculitis [9][10][11][12][13][14].…”
mentioning
confidence: 99%
“…Zu den kutanen Nebenwirkungen einer Chemotherapie mit Vinorelbin zählen unter anderem Erytheme an der Injektionsstelle, Hautnekrosen als Resultat einer Extravasation des Wirkstoffs, Erythrodysästhesie, morbilliforme Arzneimittelexantheme, eine serpentinenförmige, der darunterliegenden Vene folgende Hyperpigmentation, Recall-Radiodermatitis und leukozytoklastische Vaskulitis [9][10][11][12][13][14]. Zu den kutanen Nebenwirkungen einer Chemotherapie mit Vinorelbin zählen unter anderem Erytheme an der Injektionsstelle, Hautnekrosen als Resultat einer Extravasation des Wirkstoffs, Erythrodysästhesie, morbilliforme Arzneimittelexantheme, eine serpentinenförmige, der darunterliegenden Vene folgende Hyperpigmentation, Recall-Radiodermatitis und leukozytoklastische Vaskulitis [9][10][11][12][13][14].…”
unclassified